CUMULATIVE DOSE AND DURATION OF STATIN USE ARE ASSOCIATED WITH A REDUCED RISK OF LIVER CANCER AFTER ADJUSTING FOR AGE, FIB-4 SCORE, AND PRIOR CIRRHOSIS DIAGNOSIS IN MASLD PATIENTS; A 10-YEAR COHORT STUDY
Publication
, Conference
Karachaliou, GS; Perkins, A; Dorn, C; Wei, Q; Xu, X; Luo, S; Gobbel, G; Reeves, R; Bashir, M; Abdelmalek, M; Diehl, AM; Suzuki, A
Published in: HEPATOLOGY
2024
Duke Scholars
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
2024
Volume
80
Start / End Page
S888 / S889
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Karachaliou, G. S., Perkins, A., Dorn, C., Wei, Q., Xu, X., Luo, S., … Suzuki, A. (2024). CUMULATIVE DOSE AND DURATION OF STATIN USE ARE ASSOCIATED WITH A REDUCED RISK OF LIVER CANCER AFTER ADJUSTING FOR AGE, FIB-4 SCORE, AND PRIOR CIRRHOSIS DIAGNOSIS IN MASLD PATIENTS; A 10-YEAR COHORT STUDY. In HEPATOLOGY (Vol. 80, pp. S888–S889).
Karachaliou, Georgia Sofia, Amy Perkins, Chad Dorn, Qingyi Wei, Xiaoming Xu, Sheng Luo, Glenn Gobbel, et al. “CUMULATIVE DOSE AND DURATION OF STATIN USE ARE ASSOCIATED WITH A REDUCED RISK OF LIVER CANCER AFTER ADJUSTING FOR AGE, FIB-4 SCORE, AND PRIOR CIRRHOSIS DIAGNOSIS IN MASLD PATIENTS; A 10-YEAR COHORT STUDY.” In HEPATOLOGY, 80:S888–89, 2024.
Karachaliou GS, Perkins A, Dorn C, Wei Q, Xu X, Luo S, et al. CUMULATIVE DOSE AND DURATION OF STATIN USE ARE ASSOCIATED WITH A REDUCED RISK OF LIVER CANCER AFTER ADJUSTING FOR AGE, FIB-4 SCORE, AND PRIOR CIRRHOSIS DIAGNOSIS IN MASLD PATIENTS; A 10-YEAR COHORT STUDY. In: HEPATOLOGY. 2024. p. S888–9.
Karachaliou, Georgia Sofia, et al. “CUMULATIVE DOSE AND DURATION OF STATIN USE ARE ASSOCIATED WITH A REDUCED RISK OF LIVER CANCER AFTER ADJUSTING FOR AGE, FIB-4 SCORE, AND PRIOR CIRRHOSIS DIAGNOSIS IN MASLD PATIENTS; A 10-YEAR COHORT STUDY.” HEPATOLOGY, vol. 80, 2024, pp. S888–89.
Karachaliou GS, Perkins A, Dorn C, Wei Q, Xu X, Luo S, Gobbel G, Reeves R, Bashir M, Abdelmalek M, Diehl AM, Suzuki A. CUMULATIVE DOSE AND DURATION OF STATIN USE ARE ASSOCIATED WITH A REDUCED RISK OF LIVER CANCER AFTER ADJUSTING FOR AGE, FIB-4 SCORE, AND PRIOR CIRRHOSIS DIAGNOSIS IN MASLD PATIENTS; A 10-YEAR COHORT STUDY. HEPATOLOGY. 2024. p. S888–S889.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
2024
Volume
80
Start / End Page
S888 / S889
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics